|
covid-19 |
30 |
|
sars-cov-2 |
29 |
|
animal |
18 |
|
coronavirus |
16 |
|
interferon |
15 |
|
neutralizing antibody |
15 |
|
flavivirus |
12 |
|
transmission |
12 |
|
adult |
10 |
|
age |
10 |
|
child |
10 |
|
china |
10 |
|
damplicon |
10 |
|
influenza vaccine |
10 |
|
vaccine |
10 |
|
ba.5.2 |
9 |
|
coronavac |
9 |
|
ex vivo |
9 |
|
fc-rbd |
9 |
|
illumina sequencing |
9 |
|
model |
9 |
|
mouse |
9 |
|
omicron variant |
9 |
|
orchitis |
9 |
|
steroid |
9 |
|
temperature |
9 |
|
testis |
9 |
|
treatment |
9 |
|
xbb.1 |
9 |
|
zika |
9 |
|
zika virus |
9 |
|
2009 h1n1 influenza |
8 |
|
animal experiment |
8 |
|
antibody detection |
8 |
|
antiviral |
8 |
|
covid‐19 |
8 |
|
diagnosis |
8 |
|
dipeptidyl peptidase 4 |
8 |
|
ganglioside gm1 antibody |
8 |
|
humans |
8 |
|
hypsugo bat |
8 |
|
influenza |
8 |
|
inhibitor |
8 |
|
middle east respiratory syndrome coronavirus |
8 |
|
nanopore sequencing |
8 |
|
ns5 |
8 |
|
nsp1 |
8 |
|
rt‐pcr |
8 |
|
sars‐cov‐2 |
8 |
|
spike glycoprotein |
8 |
|
adjuvant |
7 |
|
antibody |
7 |
|
avian influenza a/h7n9 virus |
7 |
|
defective interfering viral genome |
7 |
|
immunity |
7 |
|
interferon antagonist |
7 |
|
ire1 |
7 |
|
miltefosine |
7 |
|
neurogenesis |
7 |
|
orf6 |
7 |
|
plpro |
7 |
|
reinfection |
7 |
|
single molecule real time sequencing |
7 |
|
spermatogenesis |
7 |
|
tfh |
7 |
|
upr |
7 |
|
adenovirus |
6 |
|
animals |
6 |
|
cell line, tumor |
6 |
|
diagnostic assay |
6 |
|
emerging |
6 |
|
envelope |
6 |
|
gene silencing |
6 |
|
genome |
6 |
|
intra-host diversity |
6 |
|
next-generation sequencing |
6 |
|
premembrane |
6 |
|
sars |
6 |
|
wuhan |
6 |
|
adult t-cell leukemia |
5 |
|
aim2 |
5 |
|
amino acid sequence |
5 |
|
antiviral response |
5 |
|
broad-spectrum antivirals |
5 |
|
carcinoma, hepatocellular - genetics - metabolism |
5 |
|
cell transformation, neoplastic - genetics - metabolism |
5 |
|
cloning, molecular |
5 |
|
deleted in liver cancer 2 |
5 |
|
embryo, nonmammalian - drug effects - metabolism |
5 |
|
gene expression |
5 |
|
growth suppressor protein |
5 |
|
hepatocellular carcinoma |
5 |
|
human t-cell leukemia virus type 1 |
5 |
|
ifi16 |
5 |
|
inflammasome |
5 |
|
lipid droplets |
5 |
|
liver - metabolism |
5 |
|
liver neoplasms - genetics - metabolism |
5 |
|
micrornas - genetics - metabolism |
5 |
|
mitochondria |
5 |
|
mitochondria, liver - genetics - metabolism |
5 |
|
molecular sequence data |
5 |
|
molecular sequence numbers |
5 |
|
ns5 protein |
5 |
|
pa |
5 |
|
pb1 |
5 |
|
pb2 |
5 |
|
phosphoproteins - genetics - metabolism |
5 |
|
phylogeny |
5 |
|
protein structure, tertiary - genetics |
5 |
|
protein transport - genetics |
5 |
|
pyrimidine synthesis inhibitor |
5 |
|
recombinant fusion proteins - genetics - metabolism |
5 |
|
respiratory tract infections |
5 |
|
rig-i |
5 |
|
sequence analysis, dna |
5 |
|
sequence homology, amino acid |
5 |
|
stat1 |
5 |
|
stat2 |
5 |
|
steroidogenic acute regulatory protein-related lipid transfer domain |
5 |
|
transcript isoform |
5 |
|
transcription, genetic |
5 |
|
tumor suppressor proteins - genetics - metabolism |
5 |
|
type ii interferon |
5 |
|
xenopus laevis |
5 |
|
adaptor proteins, signal transducing - metabolism |
4 |
|
apoptosis |
4 |
|
apoptosis - drug effects |
4 |
|
base sequence |
4 |
|
class iii pi3-k |
4 |
|
dice1 tumor suppressor |
4 |
|
dna primers - genetics |
4 |
|
ebv-encoded micrornas |
4 |
|
epitope |
4 |
|
epstein-barr virus (ebv) |
4 |
|
epstein-barr virus infections - complications - metabolism |
4 |
|
ex vivo human lung tissues |
4 |
|
genomic rearrangement |
4 |
|
hela cells |
4 |
|
herpesvirus 4, human |
4 |
|
interferon type i - genetics - immunology |
4 |
|
lkb1 tumor suppressor |
4 |
|
mammalia |
4 |
|
metformin |
4 |
|
mice |
4 |
|
nasopharyngeal carcinoma |
4 |
|
nasopharyngeal neoplasms - virology |
4 |
|
neoplasm proteins |
4 |
|
orf8 |
4 |
|
oxidation-reduction |
4 |
|
p53 |
4 |
|
peptide |
4 |
|
peroxidases - genetics - metabolism - pharmacology |
4 |
|
peroxiredoxin |
4 |
|
peroxiredoxin iii |
4 |
|
peroxiredoxins |
4 |
|
phenotype |
4 |
|
reactive oxygen species (ros) |
4 |
|
reactive oxygen species - metabolism |
4 |
|
redox |
4 |
|
salt-inducible kinases |
4 |
|
sars virus - immunology |
4 |
|
severe acute respiratory syndrome - immunology - virology |
4 |
|
signal transduction |
4 |
|
tax |
4 |
|
tax oncoprotein |
4 |
|
thioredoxin peroxidase |
4 |
|
tumor suppressor protein p53 - metabolism - pharmacology |
4 |
|
unfolded protein response |
4 |
|
viral matrix proteins - immunology - metabolism |
4 |
|
vps34 |
4 |
|
whole-genome sequencing |
4 |
|
3t3 cells |
3 |
|
abnormalities, multiple - genetics |
3 |
|
animalia |
3 |
|
atf4 |
3 |
|
blotting, northern |
3 |
|
blotting, western |
3 |
|
cdna cloning |
3 |
|
cell division |
3 |
|
chromosome mapping |
3 |
|
cold inducible rna binding protein |
3 |
|
creb |
3 |
|
creb-regulating transcriptional activators |
3 |
|
culture media, conditioned - metabolism |
3 |
|
cure of epstein–barr virus infection |
3 |
|
d614g |
3 |
|
dna - chemistry - genetics - isolation & purification |
3 |
|
eif2α |
3 |
|
embryo, nonmammalian - physiology |
3 |
|
embryonic development |
3 |
|
embryonic expression |
3 |
|
epidermal growth factor - antagonists & inhibitors |
3 |
|
episomal viral dna genome |
3 |
|
epstein–barr virus |
3 |
|
er stress |
3 |
|
evolution, molecular |
3 |
|
exons |
3 |
|
feasibility studies |
3 |
|
female |
3 |
|
fluorescence resonance energy transfer |
3 |
|
fungi |
3 |
|
gastrula - metabolism |
3 |
|
gastrulation |
3 |
|
gene expression regulation, developmental - drug effects |
3 |
|
gene therapy - methods |
3 |
|
genetic analysis of epstein–barr virus |
3 |
|
genetic engineering |
3 |
|
genetic vectors - pharmacology |
3 |
|
hbz |
3 |
|
herpesvirus 4, human - genetics |
3 |
|
homeodomain proteins - genetics |
3 |
|
htlv-1 |
3 |
|
human coronavirus hku1 |
3 |
|
humanized mouse model |
3 |
|
influenza a virus |
3 |
|
innate antiviral response |
3 |
|
internal ribosome entry site (ires) |
3 |
|
intracellular signaling peptides and proteins - genetics - metabolism |
3 |
|
jurkat cells |
3 |
|
kidney - cytology - embryology |
3 |
|
microscopy, confocal |
3 |
|
morphogenesis |
3 |
|
morphogenetic movement |
3 |
|
multiprotein complexes |
3 |
|
nasopharyngeal neoplasms - metabolism - therapy |
3 |
|
nervous system - embryology - metabolism |
3 |
|
nucleic acid conformation |
3 |
|
oligoribonucleotides - administration & dosage |
3 |
|
orf3a |
3 |
|
orf3b |
3 |
|
p21-activated kinases |
3 |
|
pact |
3 |
|
peroxidases - chemistry - genetics - physiology |
3 |
|
polymerase chain reaction |
3 |
|
promoter regions, genetic |
3 |
|
pronephros |
3 |
|
protein isoforms - genetics - metabolism |
3 |
|
protein sorting signals |
3 |
|
q57h |
3 |
|
reactive oxygen species |
3 |
|
recombinant fusion proteins - administration & dosage - drug effects - metabolism |
3 |
|
recombinant fusion proteins - genetics |
3 |
|
reptilia |
3 |
|
reverse transcriptase polymerase chain reaction |
3 |
|
rna - genetics - metabolism |
3 |
|
rna interference |
3 |
|
rna polymerase iii - genetics |
3 |
|
rna splicing |
3 |
|
rna, antisense - pharmacology |
3 |
|
rna, double-stranded - administration & dosage |
3 |
|
rna, double-stranded - pharmacology |
3 |
|
rna, messenger - analysis |
3 |
|
rna, messenger - metabolism |
3 |
|
rna, messenger - pharmacology |
3 |
|
rna, small interfering |
3 |
|
rna, small interfering - genetics - metabolism |
3 |
|
rna-binding proteins - genetics - metabolism |
3 |
|
rna-binding proteins - metabolism |
3 |
|
rna-guided genome editing |
3 |
|
rnai |
3 |
|
sars coronavirus |
3 |
|
sequence alignment |
3 |
|
species index: amphibia |
3 |
|
species index: bacteria (microorganisms) |
3 |
|
species index: human herpesvirus 4 |
3 |
|
spike |
3 |
|
suppression, genetic |
3 |
|
time factors |
3 |
|
tissue distribution |
3 |
|
translation initiation |
3 |
|
tumor suppressor protein p53 - antagonists & inhibitors |
3 |
|
type i interferons |
3 |
|
upstream open reading frame |
3 |
|
vertebrata |
3 |
|
x chromosome |
3 |
|
xenopus - embryology - genetics |
3 |
|
xenopus laevis - embryology - genetics |
3 |
|
xenopus proteins |
3 |
|
xmab21l2 |
3 |
|
anaphase-promoting complex |
2 |
|
anaplasma phagocytophilum |
2 |
|
bunyaviridae infections - complications - epidemiology - transmission |
2 |
|
carrier proteins. |
2 |
|
cell line |
2 |
|
cercopithecus aethiops |
2 |
|
dead-box rna helicases - immunology - metabolism |
2 |
|
dead-box rna helicases - metabolism |
2 |
|
dna damage tolerance |
2 |
|
dna, viral - genetics |
2 |
|
ebolavirus - metabolism |
2 |
|
eif-2 kinase - metabolism - physiology |
2 |
|
fever - etiology - virology |
2 |
|
gene expression regulation, viral |
2 |
|
gene expression. |
2 |
|
gene knockdown techniques |
2 |
|
gene silencing. |
2 |
|
genes, reporter |
2 |
|
hek293 cells |
2 |
|
hemorrhagic fever, ebola - metabolism |
2 |
|
herpesvirus 4, human - genetics - metabolism |
2 |
|
hiv-1 - physiology |
2 |
|
host-pathogen interactions |
2 |
|
immunity, innate |
2 |
|
influenza a virus - genetics - pathogenicity - physiology |
2 |
|
interferon type i - biosynthesis |
2 |
|
interferons - antagonists & inhibitors |
2 |
|
mucosal immunity |
2 |
|
nasal vaccine |
2 |
|
nucleoproteins. |
2 |
|
orthobunyavirus - isolation and purification |
2 |
|
orthomyxoviridae |
2 |
|
plasmids - genetics |
2 |
|
poly i-c - immunology |
2 |
|
protein subunit vaccine |
2 |
|
recombinant proteins - genetics - metabolism |
2 |
|
rev1 |
2 |
|
rev7 |
2 |
|
rna scaffold |
2 |
|
rna, double-stranded - metabolism |
2 |
|
rna, viral - genetics - metabolism |
2 |
|
rna-protein interactions. |
2 |
|
rna. |
2 |
|
self-adjuvanted |
2 |
|
signal transduction - physiology |
2 |
|
species index: influenza a virus |
2 |
|
thrombocytopenia - etiology - virology |
2 |
|
transfection |
2 |
|
translesion dna synthesis |
2 |
|
vero cells |
2 |
|
vertebrates - genetics. |
2 |
|
viral nonstructural proteins - genetics - physiology |
2 |
|
viral regulatory and accessory proteins - metabolism |
2 |
|
virus replication |
2 |
|
viruses - immunology - metabolism |
2 |
|
xenopus - genetics. |
2 |
|
aspergillus flavus |
1 |
|
biomass |
1 |
|
cadmium |
1 |
|
equilibrium |
1 |
